Second allogeneic transplantation using umbilical cord blood for a patient with relapsed ALK+ anaplastic large cell lymphoma after allogeneic bone marrow transplantation in the era of ALK inhibitors: A case report

RATIONALE: Anaplastic lymphoma kinase (ALK) + anaplastic large cell lymphoma (ALCL) is considered as a good prognosis lymphoma. However, in an extremely rare subset of patients, ALK+ ALCL with leukemic presentations is known to be chemotherapy-resistant. Although several novel therapies have been te...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Sumiko, Tashiro, Haruko, Sumiyoshi, Ritsu, Matsuo, Takuji, Yamamoto, Tadashi, Matsumoto, Kensuke, Ooi, Jun, Shirafuji, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052030/
https://www.ncbi.nlm.nih.gov/pubmed/33847688
http://dx.doi.org/10.1097/MD.0000000000025576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052030/
https://www.ncbi.nlm.nih.gov/pubmed/33847688
http://dx.doi.org/10.1097/MD.0000000000025576

Ejemplares similares